Pay in 4 interest-free payments of $6.17 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
A 2025 systematic review and meta-analysis of tirzepatide (Masson and colleagues, Reviews in Endocrine and Metabolic Disorders ) found that across seven randomized trials, tirzepatide reduced hsCRP by about 33% and IL-6 by about 18% compared to placebo and the effect held even at the lowest 5 mg dose
Most favored for patients new to peptide therapy, those optimizing for sleep and general recovery, and those who want the simplest daily protocol
Weight loss itself lowers inflammatory cytokines, but Tirzepatide also appears to reduce systemic inflammationhelping quiet the low-grade inflammation that can keep tissues from healing
Unfortunately, there are currently no direct comparative studies involving both retatrutide and tirzepatide in terms of their weight loss effectiveness
